All the news Showing 10 of 676 articles from: TherapiesGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Avalanche of hepatitis C products on the way Pharma Times / 04 April 2011 Bristol-Myers Interferon-Free Combo Cured Hepatitis Patients Bloomberg / 04 April 2011 Merck, J&J’s New Hepatitis C Treatments Fetch $31,000 in France Bloomberg / 04 April 2011 Idera Pharmaceuticals Presents Data from a Phase 1 Clinical Trial of IMO-2125 in Treatment-Naïve Genotype 1 HCV Patients at EASL 2011 Business Wire / 04 April 2011 First vaccine for viral hepatitis C could become a reality Eurekalert Inf Dis / 01 April 2011 Inhibitex Reports Positive Safety and Antiviral Data from Its Phase 1b Study of HCV Nucleotide Inhibitor INX-189 Pipeline Review / 01 April 2011 'Fantastic' data on Novartis' first-in-class hep C antiviral Pharma Times / 01 April 2011 Well-known statin could be recycled as HCV therapy supplement EASL / 01 April 2011 Results From Phase 3 REALIZE Study Showed Telaprevir-Based Therapy Significantly Improved SVR (Viral Cure) Rates in People Whose Prior Treatment For Hepatitis C Was Unsuccessful Business Wire / 31 March 2011 Interim Phase 2 Data Showed Rapid Viral Response to VX-222 in Combination with Telaprevir, Pegylated-Interferon and Ribavirin Among People With Hepatitis C Business Wire / 31 March 2011 ← Prev1...6465666768Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Transmission and prevention Diagnosis and monitoring Disease course and symptoms HCV and coinfections Living with HCV Treatment issues Side effects Therapies Liver transplants Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Noticeboard Email bulletins News feeds